TherapeuticsMD | TXMD - Ordinary Share Capital


TherapeuticsMD reported $11K in Ordinary Share Capital for its fiscal quarter ending in September of 2023.





Ordinary Share Capital Change Date
AbbVie USD 1.77B 1.75B Jun/2025
Alterity Therapeutics Limited AUD 213.97M 144.39K Jun/2023
Cipla INR 807.77M 807.43M Sep/2025
Clal Biotechnology ILS 1.61M 0 Dec/2022
Compugen USD 93.54M 3.99M Jun/2025
CSL USD 482.13M 93.87M Dec/2025
Grifols EUR 679.73M 0 Sep/2025
Novo Nordisk DKK 4.44B 3.99B Jun/2025
Pfizer USD 5.69B 1000K Sep/2025
TherapeuticsMD USD 11K 0 Sep/2023